| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Director | Director, 10% Owner
3 companies
Robert Lorne Hopfner is Director at PCVX and has filed Form 4s across 3 companies. Robert Lorne Hopfner's net worth is not public. Form 4 filings only show shares in the companies where this person is an insider; those holdings are worth an estimated $86.9M at current prices.
The biggest single holding is PCVX (~$86.6M) as Director. The PCVX filings lean toward selling, a net 724,549 shares.
Robert Lorne Hopfner has 21 Form 4 filings on record from June 2020 to October 2026, across 3 companies: Director at Rallybio (RLYB), 2021–2026; Director, 10% Owner at Evommune (EVMN), 2025; Director at Vaxcyte (PCVX), 2020–2021.
The 64 reported transactions were 40 open-market sales, 9 option or other derivative awards, 7 conversions and 3 option exercises, plus smaller numbers of other types.
Counted by filing, the open-market trades come to 3 purchases worth about $9.0M and 8 sales worth about $22.0M.
The largest open-market purchase was 576,923 shares of RLYB at an average $13.00 on August 2, 2021, about $7.5M. Twelve months later RLYB was down 48%.
The largest open-market sale was 378,698 shares of PCVX at an average $27.34 on February 10, 2021, about $10.4M.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Dec 19, 2025 | EVMN Evommune, Inc. | Director, 10% Owner | Buy | 1,000 | $17.35 | $17,350.00 | +33.0% | +29.1% | - | |
| Aug 2, 2021 | RLYB Rallybio Corp | Director | Buy | 576,923 | $13.00 | $7,499,999.00 | +34.1% | +1.1% | -48.4% | |
| Feb 10, 2021 | PCVX Vaxcyte, Inc. | Director | Sell | 378,698 | $27.34 | $10,355,466.25 | -21.2% | - | - | |
| Feb 3, 2021 | PCVX Vaxcyte, Inc. | Director | Sell | 17,002 | $25.12 | $427,066.50 | -0.9% | - | - | |
| Jan 28, 2021 | PCVX Vaxcyte, Inc. | Director | Sell | 2,000 | $25.07 | $50,140.00 | -0.1% | - | - | |
| Jan 27, 2021 | PCVX Vaxcyte, Inc. | Director | Sell | 55,254 | $25.62 | $1,415,845.34 | -3.0% | - | - | |
| Jan 22, 2021 | PCVX Vaxcyte, Inc. | Director | Sell | 30,529 | $25.28 | $771,723.38 | -1.6% | - | - | |
| Jan 19, 2021 | PCVX Vaxcyte, Inc. | Director | Sell | 91,111 | $25.71 | $2,342,558.10 | -4.6% | - | - | |
| Jan 13, 2021 | PCVX Vaxcyte, Inc. | Director | Sell | 97,343 | $26.29 | $2,558,948.07 | -4.7% | - | - | |
| Jan 8, 2021 | PCVX Vaxcyte, Inc. | Director | Sell | 145,612 | $28.30 | $4,120,276.60 | -6.6% | - | - |